OptimizeRx Corporation
OPRX
$7.77
$0.628.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -127.59% | 41.89% | -66.59% | -44.55% | 31.15% |
| Total Depreciation and Amortization | 0.00% | 0.70% | -13.31% | 174.86% | 0.00% |
| Total Amortization of Deferred Charges | 8.30% | 0.00% | 271.51% | 41.88% | 2.13% |
| Total Other Non-Cash Items | 191.76% | -8.05% | -73.01% | 239.49% | -4.68% |
| Change in Net Operating Assets | 84.99% | -86.27% | 130.69% | -3,619.44% | 118.67% |
| Cash from Operations | 129.03% | -63.08% | 133.85% | -524.79% | 162.18% |
| Capital Expenditure | 60.00% | -40.63% | -503.77% | 83.94% | -65.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -85.00% | 66.94% | -100.22% | 5,668.22% | -130.12% |
| Cash from Investing | -8.24% | 44.44% | 99.41% | -2,474.37% | -131.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 70.76% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 1,400.00% | -99.05% |
| Repurchase of Common Stock | 92.29% | -196.43% | 3.91% | -197.35% | 99.35% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | 41.86% | -42.97% | -101.77% | 10,499.22% | 95.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 635.32% | -116.45% | -66.29% | 3,288.79% | 101.75% |
